과제정보
연구 과제 주관 기관 : Small and Medium Business Administration (SMBA)
참고문헌
- Abes, S., Turner, J.J., Ivanova, G.D., Owen, D., Williams, D., Arzumanov, A., Clair, P., Gait, M.J., and Lebleu, B. (2007). Efficient splicing correction by PNA conjugation to an R6-penetratin delivery peptide. Nucleic Acids Res. 35, 4495-4502 https://doi.org/10.1093/nar/gkm418
- Boutla, A., Delidakis, C., and Tabler, M. (2003). Developmental defects by antisense-mediated inactivation of micro-RNAs 2 and 13 in Drosophila and the identification of putative target genes. Nucleic Acids Res. 31, 4973-4980 https://doi.org/10.1093/nar/gkg707
- Braasch, D.A., and Corey, D.R. (2002). Novel antisense and peptide nucleic acid strategies for controlling gene expression. Biochemistry 41, 4503-4510 https://doi.org/10.1021/bi0122112
- Bushati, N., and Cohe, S.M. (2007). microRNA functions. Annu. Rev. Cell Dev. Biol. 23, 175-205 https://doi.org/10.1146/annurev.cellbio.23.090506.123406
- Davis, S., Lollo, B., Freier, S., and Esau, C. (2006). Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res. 34, 2294-2304 https://doi.org/10.1093/nar/gkl183
- Drygin, D., Barone, S., and Bennett, F. (2007). Sequence-dependent cytotoxicity of second-generation oligonucleotides. Nucleic Acids Res. 32, 6585-6594 https://doi.org/10.1093/nar/gkh997
- Esau, C.C. (2008). Inhibition of microRNA with antisense oligonucleotides. Methods 44, 55-60 https://doi.org/10.1016/j.ymeth.2007.11.001
- Esquela-Kerscher, A., and Slack, F.J. (2006). Oncomirs-microRNAs with a role in cancer. Nature Rev. 6, 259-269 https://doi.org/10.1038/nrc1840
- Fabani, M.M., and Gait, M.J. (2008). miR-122 targeting with LNA/2′- O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates. RNA 14, 1-11
- Kang, I.G., Hwang, Y.J., Ha, J.S., Kim, D.G., and Kim, S.T. (2005). Expression of apoptosis, Bax and Bcl-2 in nasal polyps. J. Clin. Otolaryngol. 16, 264-269
- Kim, V.N. (2005). Small RNAs: classification, biogenesis, and function. Mol. Cells 19, 1-15 https://doi.org/10.1016/j.molcel.2005.05.026
- Koning, M.C., Marel, G.A., and Overhand, M. (2003). Synthetic developments towards PNA-peptide conjugates. Curr. Opin. Chem. Biol. 7, 734-740 https://doi.org/10.1016/j.cbpa.2003.10.006
- Larsen, H.J., Bentin, T., and Nielsen, P.E. (1999). Antisense properties of peptide nucleic acid. Biochim. Biophy. Acta 1489, 159-166 https://doi.org/10.1016/S0167-4781(99)00145-1
- Lebedeva, I., and Stein, C.A. (2001). Antisense oligonucleotides: promise and reality. Annu. Rev. Pharmacol. Toxicol. 41, 403-419 https://doi.org/10.1146/annurev.pharmtox.41.1.403
- Lee, H., Jeon, J.H., Lim, J.C., Choi, H., Yoon, Y., and Kim, S.K. (2007). Peptide nucleic acid synthesis by novel amide formation. Org. Lett. 9, 3291-3293 https://doi.org/10.1021/ol071215h
- Naguibneva, I., Ameyar-Zazoua, M., Nonne, N., Polesskaya, A., Ait-Si-Ali, S., Groisman, R., Souidi, M., Pritchard, L.L., and Harel-Bellan, A. (2006). An LNA-based loss-of-function assay for micro-RNAs. Biomed. Pharm. 60, 633-638 https://doi.org/10.1016/j.biopha.2006.07.078
- Orom, U.A., Kauppinen, S., and Lund, A.H. (2006). LNA-midified oligonucleotides mediate specific inhibition of microRNA function. Gene 372, 137-141 https://doi.org/10.1016/j.gene.2005.12.031
- Pellestor, F., and Paulasova, P. (2004). The peptide nucleic acids, efficient tools for molecular diagnosis (Review). Int. J. Mol. Med. 13, 521-525
- Rayburn, E.R., and Zhang, R. (2008). Antisense, RNAi, and gene silencing strategies for therapy: Mission possible or impossible? Drug Discov. Today 13, 513-521 https://doi.org/10.1016/j.drudis.2008.03.014
- Swayze, E.E., Siwkowski, A.M., Wancewicz, E.V., Migawa, M.T., Wyrzykiewicz, T.K., Hung, G., Monia, B.P., and Bennett, C.F. (2007). Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals. Nucleic Acids Res. 35, 687-700 https://doi.org/10.1093/nar/gkl1071
- Uhlmann, E., Will, D.W., Breipohl, G., Langner, D., and Ryte, A. (1996). Synthesis and properties of PNA/DNA chimeras. Angew. Chem. Int. Ed. Engl. 35, 2632-2635 https://doi.org/10.1002/anie.199626321
- Wang, B., Doench., J.G., and Novina, C.D. (2007). Analysis of microRNA effector functions in vitro. Methods 43, 91-104 https://doi.org/10.1016/j.ymeth.2007.04.003
- Watts, J.K., Deleavey, G.F., and Damha, M.J. (2008). Chemically modified siRNA: tools and applications. Drug Discov. Today 13, 842-855 https://doi.org/10.1016/j.drudis.2008.05.007
- Weiler, J., Hunziker, J., and Hall, J. (2006). Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? Gene Ther. 13, 496-502 https://doi.org/10.1038/sj.gt.3302654
- Wittung, P., Kajanus, J., Edwards, K., Haaima, G., Nielsen, P.E., Norden, B., and Malmstrom B.G. (1995). Phospholipid membrane permeability of peptide nucleic acid. FEBS Lett. 375, 27-29 https://doi.org/10.1016/0014-5793(95)01153-6
- Xia, L., Zhang, D., Du, R., Pan, Y., Zhao, L., Sun, S., Hong, L., Liu, J., and Fan, D. (2008). miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int. J. Cancer 123, 372-379 https://doi.org/10.1002/ijc.23501
피인용 문헌
- PNA-Based Antisense Oligonucleotides for MicroRNAs Inhibition in the Absence of a Transfection Reagent vol.20, pp.5, 2009, https://doi.org/10.1089/oli.2010.0238
- MicroRNA fate upon targeting with anti-miRNA oligonucleotides as revealed by an improved Northern-blot-based method for miRNA detection vol.17, pp.5, 2009, https://doi.org/10.1261/rna.2533811
- miRNA therapeutics: delivery and biological activity of peptide nucleic acids targeting miRNAs vol.3, pp.6, 2009, https://doi.org/10.2217/epi.11.90
- Potent and sustained cellular inhibition of miR-122 by lysine-derivatized peptide nucleic acids (PNA) and phosphorothioate locked nucleic acid (LNA)/2'-O-methyl (OMe) mixmer anti-miRs in the absence o vol.2, pp.3, 2009, https://doi.org/10.4161/adna.17731
- Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth vol.13, pp.1, 2009, https://doi.org/10.1186/bcr2803
- Basic peptide-morpholino oligomer conjugate that is very effective in killing bacteria by gene-specific and nonspecific modes vol.108, pp.40, 2009, https://doi.org/10.1073/pnas.1112561108
- Targeting microRNAs involved in human diseases: A novel approach for modification of gene expression and drug development vol.82, pp.10, 2011, https://doi.org/10.1016/j.bcp.2011.08.007
- Cellular Uptakes, Biostabilities and Anti-miR-210 Activities of Chiral Arginine-PNAs in Leukaemic K562 Cells vol.13, pp.9, 2012, https://doi.org/10.1002/cbic.201100745
- Chemical structure requirements and cellular targeting of microRNA-122 by peptide nucleic acids anti-miRs vol.40, pp.5, 2012, https://doi.org/10.1093/nar/gkr885
- Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA vol.1, pp.6, 2009, https://doi.org/10.1038/mtna.2012.18
- PNA-based microRNA inhibitors elicit anti-inflammatory effects in microglia cells vol.49, pp.39, 2009, https://doi.org/10.1039/c2cc36540e
- Upstream mononucleotide A-repeats play a cis -regulatory role in mammals through the DICER1 and Ago proteins vol.41, pp.19, 2009, https://doi.org/10.1093/nar/gkt685
- Involvement of EBV-encoded BART-miRNAs and Dysregulated Cellular miRNAs in Nasopharyngeal Carcinoma Genesis vol.14, pp.10, 2013, https://doi.org/10.7314/apjcp.2013.14.10.5637
- Insights on chiral, backbone modified peptide nucleic acids: Properties and biological activity vol.5, pp.3, 2009, https://doi.org/10.1080/1949095x.2015.1107176
- Peptide nucleic acids: a review on recent patents and technology transfer vol.24, pp.3, 2009, https://doi.org/10.1517/13543776.2014.863874
- In Situ Synthesis of Peptide Nucleic Acids in Porous Silicon for Drug Delivery and Biosensing vol.25, pp.7, 2009, https://doi.org/10.1021/bc5001092
- Inhibition of miR-21 by 3′/5′-Serinyl-Capped 2′-O-Methyl RNA Interspersed with 2′-O-(2-Amino-3-Methoxypropyl) Uridine Units vol.26, pp.5, 2009, https://doi.org/10.1089/nat.2015.0591
- Clamping of RNA with PNA enables targeting of microRNA vol.14, pp.23, 2009, https://doi.org/10.1039/c6ob00516k
- MicroRNA-21 and PDCD4 expression during in vitro oocyte maturation in pigs vol.14, pp.None, 2016, https://doi.org/10.1186/s12958-016-0152-2
- Focus on PNA Flexibility and RNA Binding using Molecular Dynamics and Metadynamics vol.7, pp.None, 2009, https://doi.org/10.1038/srep42799
- Therapeutic targeting of non-coding RNAs in cancer vol.474, pp.24, 2009, https://doi.org/10.1042/bcj20170079
- Anti-miRNA oligonucleotides: A comprehensive guide for design vol.15, pp.3, 2009, https://doi.org/10.1080/15476286.2018.1445959
- Immune Regulation of Tissue Repair and Regeneration via miRNAs—New Therapeutic Target vol.6, pp.None, 2009, https://doi.org/10.3389/fbioe.2018.00098
- Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs vol.19, pp.1, 2009, https://doi.org/10.3390/ijms19010065
- Targeted Delivery of an siRNA/PNA Hybrid Nanocomplex Reverses Carbon Tetrachloride‐Induced Liver Fibrosis vol.2, pp.8, 2019, https://doi.org/10.1002/adtp.201900046
- RNA Secondary Structure-Based Design of Antisense Peptide Nucleic Acids for Modulating Disease-Associated Aberrant Tau Pre-mRNA Alternative Splicing vol.24, pp.16, 2009, https://doi.org/10.3390/molecules24163020
- Walking through the wonder years of artificial DNA: peptide nucleic acid vol.47, pp.10, 2009, https://doi.org/10.1007/s11033-020-05819-3
- Recent Advances in Oligonucleotide Therapeutics in Oncology vol.22, pp.7, 2009, https://doi.org/10.3390/ijms22073295
- Recognition of Target Site in Various Forms of DNA and RNA by Peptide Nucleic Acid (PNA): From Fundamentals to Practical Applications vol.94, pp.6, 2009, https://doi.org/10.1246/bcsj.20210086
- Toward conditional control of Smac mimetic activity by RNA‐templated reduction of azidopeptides on PNA or 2′‐OMe‐RNA vol.112, pp.12, 2009, https://doi.org/10.1002/bip.23466